Index of artpub/2022/pmc_9425310/

Moreno, Carol
First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab : final analysis of the randomized, phase III iLLUMINATE trial
2022
https://ddd.uab.cat/record/279345